TC1711-02

Secondary Therapeutic Drug Levitiracetam  (Keppra) analysis is now performed in-house.

The analytical methodology is changed from HPLC to immunoassay.  There is a 99.129% correlation between the methodologies.

Test turn-around time is reduced from 5 days to same day (< 24 hours).

Testing is offered Monday - Friday until 5:00 p.m.

Saturday and Sunday between 8:00 a.m. and 12:00 p.m.

The reference range remains unchanged 10-40 ug/mL

Connect With Us

Contact Us
General Inquiries
Phone:  (806) 771-9988
Toll Free: (877) 994-5227



Client Services
Main Line, Option 6
Direct:  (806) 370-8740
 
© 2017 Leannah Investment Partners LTD. All Rights Reserved.

Search